These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9035117)

  • 1. Biotechnology, bioremediation, and blue genes.
    Bialy H
    Nat Biotechnol; 1997 Feb; 15(2):110. PubMed ID: 9035117
    [No Abstract]   [Full Text] [Related]  

  • 2. The biotechnology bubble machine.
    Rasnick D
    Nat Biotechnol; 2003 Apr; 21(4):355-6. PubMed ID: 12665813
    [No Abstract]   [Full Text] [Related]  

  • 3. GM giants pair up to do battle.
    Mitchell P
    Nat Biotechnol; 2007 Jul; 25(7):695-6. PubMed ID: 17621277
    [No Abstract]   [Full Text] [Related]  

  • 4. Cures on the cob.
    Roosevelt M
    Time; 2003 May; 161(21):56-7. PubMed ID: 12800326
    [No Abstract]   [Full Text] [Related]  

  • 5. Minicrash tests biotechnology investors and companies as market fluctuates.
    Dorey E
    Nat Biotechnol; 1997 Dec; 15(13):1333. PubMed ID: 9415878
    [No Abstract]   [Full Text] [Related]  

  • 6. Negotiating the RNAi patent thicket.
    Schmidt C
    Nat Biotechnol; 2007 Mar; 25(3):273-5. PubMed ID: 17344871
    [No Abstract]   [Full Text] [Related]  

  • 7. Intellectual property protection for plant-related inventions in Europe.
    Fleck B; Baldock C
    Nat Rev Genet; 2003 Oct; 4(10):834-8. PubMed ID: 14526379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The quiet revolution.
    Nat Biotechnol; 2003 Jul; 21(7):715. PubMed ID: 12833072
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology consortia versus multifirm alliances: paradigm shift at work?
    Persidis A; Persidis A
    Nat Biotechnol; 1996 Dec; 14(13):1657-60. PubMed ID: 9634847
    [No Abstract]   [Full Text] [Related]  

  • 10. Ownership at too high a price?
    Nat Biotechnol; 2003 Sep; 21(9):953. PubMed ID: 12949537
    [No Abstract]   [Full Text] [Related]  

  • 11. Integrating the intellectual property value chain.
    Barrett B; Crawford D
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE43-6. PubMed ID: 12089587
    [No Abstract]   [Full Text] [Related]  

  • 12. Intellectual property as a foundation for funding.
    Meltzer SL; Marks MS; McCormick JT
    Nat Biotechnol; 2002 Jul; 20 Suppl():BE47-50. PubMed ID: 12089588
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnology. Indian centre receives funds.
    Jayaraman KS
    Nature; 1992 Jan; 355(6357):192. PubMed ID: 1731207
    [No Abstract]   [Full Text] [Related]  

  • 14. Biotechs sue Columbia over fourth Axel patent.
    Howard K
    Nat Biotechnol; 2003 Sep; 21(9):955-6. PubMed ID: 12949538
    [No Abstract]   [Full Text] [Related]  

  • 15. Inherited wealth.
    Wyke A
    Economist; 1988 Apr; 307():3-18. PubMed ID: 17256228
    [No Abstract]   [Full Text] [Related]  

  • 16. Animals as inventions: biotechnology and intellectual property rights.
    Sagoff M
    Rep Inst Philos Public Policy; 1996; 16(1):15-9. PubMed ID: 11654360
    [No Abstract]   [Full Text] [Related]  

  • 17. Taking knowledge from bench to bank.
    Horton B; Wickware P; Gershon D; Gavaghan H
    Nature; 1998 Sep; 395(6700):409-14. PubMed ID: 9759734
    [No Abstract]   [Full Text] [Related]  

  • 18. Protecting innovation in biotechnology startups.
    Steffe EK; Shea TJ
    Nat Biotechnol; 2003 Jul; 21 Suppl():BE51-3. PubMed ID: 12874982
    [No Abstract]   [Full Text] [Related]  

  • 19. Public biotechnology 2004--the numbers.
    Lähteenmäki R; Lawrence S
    Nat Biotechnol; 2005 Jun; 23(6):663-71. PubMed ID: 15940232
    [No Abstract]   [Full Text] [Related]  

  • 20. Unlocking the money-making potential of RNAi.
    Howard K
    Nat Biotechnol; 2003 Dec; 21(12):1441-6. PubMed ID: 14647324
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.